-
Ablation of AVNRT in patients with AF was associated with improved outcomes compared with those with other triggers of AF.
-
In fiscal 2003, 10.8% of Medicare patients undergoing cardioverter-defibrillator implantation experienced one or more early complications, associated with significant increases in LOS and costs.
-
Although levels of various inflammatory biomarkers are significantly related to future cardiovascular risk, their incremental predictive value is modest.
-
Reduced renal function may define a subset of patients most likely to benefit from ACE-inhibitor therapy for cardiovascular protection.
-
Commonly used drugs in patients with coronary disease or COPD may be beneficial in the absence of specific guideline recommendations at present.
-
Even a device which makes perfect physiological sense may not help us achieve the goals of improved outcomes for out-of-hospital cardiac arrest victims.
-
Rescue PCI in the setting of early fibrinolytic failure improves mortality, but this is tempered by a possible increase in the risk of thromboembolic stroke.
-
-
Although time to reperfusion is correlated with mortality in ST elevation myocardial infarction (STEMI) treated with fibrinolytics, its importance in patients treated with percutaneous coronary interventions (PCI) is less clear.
-
Do long-acting beta agonist inhalers increase the severity of asthma? Yes, according to the results from a large meta-analysis recently published in the Annals of Internal Medicine.